Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure
暂无分享,去创建一个
C. W. Heegaard | J. Rasmussen | G. E. Gilbert | S. Pipe | J. Shi | G. Gilbert | Jialan Shi | Jan T. Rasmussen | Gary E. Gilbert
[1] V. Novakovic,et al. Crystal Structure of Lactadherin C2 Domain at 1.7Å Resolution with Mutational and Computational Analyses of Its Membrane-binding Motif* , 2008, Journal of Biological Chemistry.
[2] J. Molkentin,et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. , 2008, Blood.
[3] Tony Yeung,et al. Membrane Phosphatidylserine Regulates Surface Charge and Protein Localization , 2008, Science.
[4] C. W. Heegaard,et al. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[5] S. Dasgupta,et al. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. , 2006, Translational research : the journal of laboratory and clinical medicine.
[6] M. V. van Zandvoort,et al. The Glycoprotein VI-Phospholipase C&ggr;2 Signaling Pathway Controls Thrombus Formation Induced by Collagen and Tissue Factor In Vitro and In Vivo , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[7] C. Kempton,et al. Platelet Heterogeneity: Variation in Coagulation Complexes on Platelet Subpopulations , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[8] C. W. Heegaard,et al. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. , 2004, Biochimica et biophysica acta.
[9] S. Lord,et al. Fibrin stimulates platelets to increase factor VIIIa binding site expression , 2004, Journal of thrombosis and haemostasis : JTH.
[10] P. Walsh,et al. A Subpopulation of Platelets Responds to Thrombin- or SFLLRN-stimulation with Binding Sites for Factor IXa* , 2004, Journal of Biological Chemistry.
[11] L. Ritter,et al. Caspase inhibition decreases both platelet phosphatidylserine exposure and aggregation: caspase inhibition of platelets. , 2004, Thrombosis research.
[12] G. E. Gilbert,et al. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. , 2003, Blood.
[13] G. E. Gilbert,et al. Role of the liver in regulating numbers of circulating neutrophils. , 2001, Blood.
[14] S. Fedosov,et al. Functional analyses of two cellular binding domains of bovine lactadherin. , 2000, Biochemistry.
[15] L. Alberio,et al. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. , 2000, Blood.
[16] E. Nabel,et al. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. , 2000, Blood.
[17] G.,et al. Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .
[18] C. Benedict,et al. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. , 1997, Circulation.
[19] G. E. Gilbert,et al. Partial activation of the factor VIIIa-factor IXa enzyme complex by dihexanoic phosphatidylserine at submicellar concentrations. , 1997, Biochemistry.
[20] P. Walsh,et al. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles. , 1996, Biochemistry.
[21] G. E. Gilbert,et al. Activation of the Factor VIIIa-Factor IXa Enzyme Complex of Blood Coagulation by Membranes Containing Phosphatidyl-L-serine (*) , 1996, The Journal of Biological Chemistry.
[22] P. Williamson,et al. Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. , 1995, Biochemistry.
[23] G. Willems,et al. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. , 1994, Biochemistry.
[24] K. Mann,et al. Intact platelet membranes, not platelet-released microvesicles, support the procoagulant activity of adherent platelets. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[25] G. E. Gilbert,et al. Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine. , 1993, Biochemistry.
[26] M. Sefton,et al. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. , 1993, The Journal of biological chemistry.
[27] T. Müller,et al. The Effects of Heparin and Annexin V on Fibrin Accretion after Injury in the Jugular Veins of Rabbits , 1993, Thrombosis and Haemostasis.
[28] J. Freyssinet,et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. , 1993, Blood.
[29] G. E. Gilbert,et al. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). , 1992, The Journal of biological chemistry.
[30] P. Sims,et al. Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. , 1992, Blood.
[31] B. Furie,et al. Platelet-derived microparticles express high affinity receptors for factor VIII. , 1991, The Journal of biological chemistry.
[32] J. Römisch,et al. In-vivo antithrombotic potency of placenta protein 4 (annexin V). , 1991, Thrombosis research.
[33] A. Bui,et al. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[34] H C Hemker,et al. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. , 1990, The Journal of biological chemistry.
[35] H. Hemker,et al. Binding of vascular anticoagulant a(VAC)a to Planar Phospholipid Bilayers , 1990 .
[36] P. Walsh,et al. Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome. , 1989, The Journal of clinical investigation.
[37] K. Fujikawa,et al. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family. , 1988, Biochemistry.
[38] H. Hemker,et al. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. , 1985, European journal of biochemistry.
[39] J. George,et al. Isolation of human platelet membrane microparticles from plasma and serum. , 1982, Blood.
[40] H. Hemker,et al. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. , 1982, European journal of biochemistry.
[41] K. Mann,et al. Interaction of coagulation factor V and factor Va with platelets. , 1979, The Journal of biological chemistry.
[42] E W Moore,et al. Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes. , 1970, The Journal of clinical investigation.